Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial

Berl, Tomás; G. Hunsicker, Lawrence; B. Lewis, Julia; A. Pfeffer, Marc; G. Porush, Jerome; Rouleau, Jean‐Lucien; Drury, Paul; Esmatjes, Enric; E. Hricik, Donald; A. Pohl, Marc; Raz, Itamar; Vanhille, Philippe; Wiegmann, Thomas; M. Wolfe, Bernard; Locatelli, Francesco; Z. Goldhaber, Samuel; J. Lewis, Edmund

doi:10.1681/asn.2004090763

Public

Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial

Published in Journal of the American Society of Nephrology • Jun 1, 2005

Authors:

Tomás Berl

Lawrence G. Hunsicker

Julia B. Lewis

Abstract

Elevated arterial pressure enhances the risk for cardiovascular (CV) events in patients with diabetic nephropathy. The optimal BP and the component of the elevated BP that affect the risk have not been defined. A post hoc analysis was performed to assess the impact of achieved systolic, diastolic, a...

Subject

Irbesartan

Medicine

Blood pressure

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!